steroids-not-better-than-dmeInjecting a corticosteroid, triamcinolone, directly into the eye can slowdown the progression of proliferative diabetic retinopathy, a complication of diabetes that frequently leads to blindness.

This finding was revealed by a team of researchers led by specialists at the Johns Hopkins Wilmer Eye Institute.

It was however noted by the study authors that steroid use in the eye may raise the risks of glaucoma and cataract and laser photo-coagulation remains the treatment of choice till the time a new treatment option is formulated that can reproduce the positive effects of steroids without the associated risks of such use.

Neil M. Bressler, the James P. Gills Professor of Ophthalmology and chief of the Retina Division of the Johns Hopkins Wilmer Eye Institute, chair of the government-sponsored Diabetic Retinopathy Clinical Research Network, remarked that though steroid treatment works, it cannot be recommended on a routinely basis due to the safety issues.